Literature DB >> 15699422

Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection.

J Xu1, P Dennehy, H Keyserling, L E Westerman, Y Wang, R C Holman, J R Gentsch, R I Glass, B Jiang.   

Abstract

We examined sera from 42 patients 1 to 30 months of age for rotavirus immunoglobulin M (IgM), IgA, IgG, and IgG subclasses and sought to determine if serum antibody could serve as a reliable marker for prediction of disease severity. Infants in the first few months of life usually had high maternal IgG titers and, when they were infected with rotavirus, had low IgM titers or no IgM in acute-phase sera and poor seroconversions 3 weeks later, suggesting that maternal antibodies had inhibited viral replication and antibody responses. All patients > or =6 months of age had IgM in acute-phase sera, indicating that IgM is a good marker for acute rotavirus infection. IgG was the best overall predictor of an infection, as the convalescent-phase sera of 81% of the patients had a fourfold rise in the IgG titer. IgA titers in convalescent-phase sera and conversion rates were higher among patients > or =12 months of age than among children younger than 12 months. IgG1 was the predominant subclass detected in the acute-phase sera of some children and in all 28 convalescent-phase serum samples examined. Patients with preexisting acute-phase IgG titers of > or =100 or > or =200 had diarrhea that was less severe or of a shorter duration. These results indicate that serum IgG is the most reliable marker for seroconversion and is a consistent proxy for protection against severe disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699422      PMCID: PMC549315          DOI: 10.1128/CDLI.12.2.273-279.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  36 in total

Review 1.  Diversity of antibody-mediated immunity at the mucosal barrier.

Authors:  J P Bouvet; V A Fischetti
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

2.  Rotavirus-specific subclass antibody and cytokine responses in Bangladeshi children with rotavirus diarrhoea.

Authors:  Tasnim Azim; M Hasan Zaki; Goutam Podder; Novera Sultana; M Abdus Salam; S Moshfiqur Rahman; David A Sack
Journal:  J Med Virol       Date:  2003-02       Impact factor: 2.327

3.  The development of immunoglobulin levels in man.

Authors:  M Allansmith; B H McClellan; M Butterworth; J R Maloney
Journal:  J Pediatr       Date:  1968-02       Impact factor: 4.406

4.  Opsonization of alphaviruses in hamsters.

Authors:  P B Jahrling; R A Hesse; A O Anderson; J D Gangemi
Journal:  J Med Virol       Date:  1983       Impact factor: 2.327

5.  Serum and intestinal immune response to rotavirus enteritis in children.

Authors:  G P Davidson; R J Hogg; C P Kirubakaran
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

Review 6.  The role of serum antibodies in the protection against rotavirus disease: an overview.

Authors:  Baoming Jiang; Jon R Gentsch; Roger I Glass
Journal:  Clin Infect Dis       Date:  2002-04-22       Impact factor: 9.079

7.  Serum antibody as a marker of protection against natural rotavirus infection and disease.

Authors:  F R Velázquez; D O Matson; M L Guerrero; J Shults; J J Calva; A L Morrow; R I Glass; L K Pickering; G M Ruiz-Palacios
Journal:  J Infect Dis       Date:  2000-10-23       Impact factor: 5.226

8.  Cytokines as mediators for or effectors against rotavirus disease in children.

Authors:  B Jiang; L Snipes-Magaldi; P Dennehy; H Keyserling; R C Holman; J Bresee; J Gentsch; R I Glass
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

9.  Measurement of antirotavirus IgM/IgA/IgG responses in the serum samples of Indian children following rotavirus diarrhoea and their mothers.

Authors:  Pratibha G Ray; Shobhana D Kelkar
Journal:  J Med Virol       Date:  2004-03       Impact factor: 2.327

10.  Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children.

Authors:  R F Bishop; G L Barnes; E Cipriani; J S Lund
Journal:  N Engl J Med       Date:  1983-07-14       Impact factor: 91.245

View more
  9 in total

Review 1.  Use of Pathogen-Specific Antibody Biomarkers to Estimate Waterborne Infections in Population-Based Settings.

Authors:  Natalie G Exum; Nora Pisanic; Douglas A Granger; Kellogg J Schwab; Barbara Detrick; Margaret Kosek; Andrey I Egorov; Shannon M Griffin; Christopher D Heaney
Journal:  Curr Environ Health Rep       Date:  2016-09

2.  Rotavirus acceleration of murine type 1 diabetes is associated with a T helper 1-dependent specific serum antibody response and virus effects in regional lymph nodes.

Authors:  J A Pane; N L Webster; K L Graham; G Holloway; C Zufferey; B S Coulson
Journal:  Diabetologia       Date:  2012-12-14       Impact factor: 10.122

3.  Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea.

Authors:  Yuhuan Wang; Penelope H Dennehy; Harry L Keyserling; Kevin Tang; Jon R Gentsch; Roger I Glass; Baoming Jiang
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

Review 4.  Rotaviruses: From Pathogenesis to Disease Control-A Critical Review.

Authors:  Cornelius A Omatola; Ademola O Olaniran
Journal:  Viruses       Date:  2022-04-22       Impact factor: 5.818

5.  Parenterally Administered P24-VP8* Nanoparticle Vaccine Conferred Strong Protection against Rotavirus Diarrhea and Virus Shedding in Gnotobiotic Pigs.

Authors:  Ashwin Ramesh; Jiangdi Mao; Shaohua Lei; Erica Twitchell; Ashton Shiraz; Xi Jiang; Ming Tan; And Lijuan Yuan
Journal:  Vaccines (Basel)       Date:  2019-11-06

6.  In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine.

Authors:  Katayi Mwila Kazimbaya; Caroline C Chisenga; Michelo Simuyandi; Cynthia Mubanga Phiri; Natasha Makabilo Laban; Samuel Bosomprah; Sallie R Permar; Sody Munsaka; Roma Chilengi
Journal:  PLoS One       Date:  2020-11-10       Impact factor: 3.240

7.  A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein.

Authors:  Owen Kavanagh; Xi-Lei Zeng; Sasirekha Ramani; Indrani Mukhopadhya; Sue E Crawford; Gagandeep Kang; Mary K Estes
Journal:  J Virol Methods       Date:  2012-11-23       Impact factor: 2.014

8.  Association of Maternal Immunity with Rotavirus Vaccine Immunogenicity in Zambian Infants.

Authors:  Roma Chilengi; Michelo Simuyandi; Lauren Beach; Katayi Mwila; Sylvia Becker-Dreps; Devy M Emperador; Daniel E Velasquez; Samuel Bosomprah; Baoming Jiang
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

9.  Association of serum antibodies with protection against rotavirus infection and disease in South Indian children.

Authors:  Prasanna Premkumar; Ben Lopman; Sasirekha Ramani; Anu Paul; Beryl Gladstone; Jayaprakash Muliyil; Indrani Mukhopadhya; Umesh Parashar; Gagandeep Kang
Journal:  Vaccine       Date:  2014-08-11       Impact factor: 3.641

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.